JPM Week: Why Your Deals Stall After the First ‘Yes'
Why Deals Stall After the First “Yes” and the Promises That Actually Convert Pilots to Contracts
What enterprise buyers hear, where trust breaks, and how to make promises that hold up in real implementations.
Why do buyers seem excited… then go quiet?
Why do pilots succeed but never convert?
Why does procurement suddenly ‘slow down’ after promising conversations?
In enterprise health organizations, enthusiasm isn’t the decision. After early meetings, products are translated internally across clinical, IT, compliance, and procurement teams, each with their own risk lens. This is where many deals stall: not because the product is weak, but because early promises don’t survive internal scrutiny.
In this session, we break down the hidden gap between what founders say in early conversations and what enterprise buyers actually hear. Drawing from real deployments across health systems, pharma, and medtech, we’ll unpack ten common promises that unintentionally erode trust and show what credible, confidence-building alternatives sound like instead.
This is not about “selling less.”
It’s about making promises that buyers can say yes to and stand behind internally.
Food will be provided.
Who should attend
Founders, early employees, and builders in healthtech, care delivery, AI/ML in healthcare, clinical operations, and enterprise-facing digital health products. JPM Health conference attendees and other interested individuals.
Format
10-minute presentation (The Agentic)
15-minute presentation (Vahana Labs)
25-minute AMA (Moderated by Lauren Taylor)
Open networking afterward.
Timing
11:15-11:30 registration & lunch
11:30-12:20 presentations & panel
12:20-12:45 networking
Co-hosted by:
Arvita Tripati, MBA, Product & GTM Advisory at Vahana Labs
Gulia Ismagilova, MBA, AI Agentic solutions for Healthcare Life Sciences startups at TheAgentic.
Lauren M Taylor, GP @ Scaling Care
Arvita Tripati is a product and enterprise readiness GTM leader with deep experience building and launching regulated healthtech and AI-enabled products. She has led more than 30 FDA-regulated and enterprise-grade products across companies including Korio, Clip Health, AliveCor, Vineti, Endpoint Clinical, and Accuray. Her work focuses on the practical reality of introducing new tools into clinical workflows, navigating enterprise evaluation, and building the trust infrastructure required for scale. Through Vahana Labs, she advises founders, funds, and operators on product readiness, governance, and GTM strategy in highly regulated environments.
Lauren M Taylor is an angel investor in health and bio, and GP at Scaling Care, an early-stage venture firm focused on bench-to-bedside infrastructure. She works hands-on with founders from validation through commercialization, with a focus on unlocking non-dilutive capital for trials and pilots. She brings a network of operator-founders, clinicians, and translational leaders, and regularly supports teams navigating the operational realities that determine whether innovation succeeds beyond the first site.
Jennifer Gibson is a product and healthtech leader with over 18 years of experience building innovative, data-driven healthcare solutions at the intersection of clinical care, technology, and human experience. She has led teams at Apple and early-stage startups, and more recently has focused on applying AI and advanced analytics to create scalable, user-centered digital health products.
Dr. Sara Sagui Henson leads Clinical Research at Modern Health. As a health psychologist with over a decade of evidence generation experience, she has a passion for leveraging technology to solve important healthcare problems. Sara loves using science and real-world data to evaluate and validate how innovative products and services in the digital health space can improve equitable access and health outcomes.
Theresa Neil is a Design Executive, CPO, Fractional Leader, Technical Diligence Advisor, Board Member, and Advisor. She works with founders, investors, and innovation teams to define product strategy, ensure executional excellence for digital product and service design, and assess the right technology and engineering partners to trust at critical growth stages.
For healthtech founders building AI-powered products, TheAgentic's enterprise-grade infrastructure lets you make concrete promises about security and scalability that IT and compliance teams can actually verify. Instead of vague claims that erode during internal review, you can point to specific capabilities that address customers’ exact needs.